Barrier Contraceptive Devices Three-Month Data OK For Approval, Panel Says
This article was originally published in The Gray Sheet
Executive Summary
Three-month data is sufficient in demonstrating the efficacy of female barrier contraceptives in preventing pregnancy, a majority of FDA's Obstetrics and Gynecology Devices Panel agreed Oct. 4.
You may also be interested in...
YAMA'S LEA'S SHIELD FEMALE BARRIER CONTRACEPTIVE NEEDS 200-PATIENT STUDY, FDA PANEL FINDS; EXISTING DATA INSUFFICIENT TO ESTABLISH PREGNANCY RATE
Yama's Lea's Shield silicone vaginal barrier contraceptive device should be evaluated in a study of at least 200 subjects, FDA's Obstetrics and Gynecology Devices Panel concluded at its Oct. 21 meeting in Rockville, Maryland.
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.